Literature DB >> 23554526

Methadone maintenance treatment in Spain: the success of a harm reduction approach.

Marta Torrens1, Francina Fonseca, Claudio Castillo, Antonia Domingo-Salvany.   

Abstract

PROBLEM: During the 1980s, Spain had very strict laws limiting access to opioid agonist maintenance treatment (OAMT). Because of this, mortality among people who used illicit opioids and other illicit drugs was high. Spain was also the European country with the highest number of cases of acquired immunodeficiency syndrome transmitted through illicit drug injection. APPROACH: The rapid spread of human immunodeficiency virus (HIV) infection among people using heroin led to a shift from a drug-free approach to the treatment of opioid dependence to one focused on harm reduction. A substantial change in legislation made it possible to meet public health needs and offer OAMT as part of harm reduction programmes in the public health system, including prisons. LOCAL
SETTING: Legislative changes were made throughout the country, although at a different pace in different regions. RELEVANT CHANGES: Legal changes facilitated the expansion of OAMT, which has achieved a coverage of 60%. A parallel reduction in the annual incidence of HIV infection has been reported. Reductions in morbidity and mortality and improved health-related quality of life have been described in patients undergoing OAMT. LESSONS LEARNT: The treatment of opioid dependence has been more heavily influenced by moral concepts and prejudices that hinder legislation and interfere with the implementation of OAMT than by scientific evidence. To fulfil public health needs, OAMT should be integrated in harm reduction programmes offered primarily in public facilities, including prisons. Longitudinal studies are needed to detect unmet needs and evaluate programme impact and suitability.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23554526      PMCID: PMC3605010          DOI: 10.2471/BLT.12.111054

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  Methadone and quality of life.

Authors:  M Torrens; A Domingo-Salvany; J Alonso; C Castillo; L San
Journal:  Lancet       Date:  1999-03-27       Impact factor: 79.321

2.  Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates.

Authors:  Gregorio Barrio; María J Bravo; M Teresa Brugal; Mercedes Díez; Enrique Regidor; María José Belza; Luis de la Fuente
Journal:  Addiction       Date:  2012-02-11       Impact factor: 6.526

3.  Retention in a low-threshold methadone maintenance program.

Authors:  M Torrens; C Castillo; V Pérez-Solá
Journal:  Drug Alcohol Depend       Date:  1996-05       Impact factor: 4.492

4.  A multicentre study to introduce naltrexone for opiate dependence in Spain.

Authors:  F García-Alonso; M Gutierrez; L San; J Bedate; J Forteza-Rei; F Rodríguez-Artalejo; R Palop; M López-Alvarez; J C Pérez de los Cobos; J Cami
Journal:  Drug Alcohol Depend       Date:  1989-04       Impact factor: 4.492

5.  Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.

Authors:  M T Brugal; A Domingo-Salvany; R Puig; G Barrio; P García de Olalla; L de la Fuente
Journal:  Addiction       Date:  2005-07       Impact factor: 6.526

6.  The effects of HIV infection on the development of methadone maintenance treatment in Spain.

Authors:  M Torrens; J Camí
Journal:  Addiction       Date:  1994-12       Impact factor: 6.526

Review 7.  [Guidelines and criteria concerning the admission of heroin addicts to the general hospital].

Authors:  J Camí Morell; S de Torres Sanahuja; L San Molina
Journal:  Med Clin (Barc)       Date:  1984-02-25       Impact factor: 1.725

8.  Methadone treatment in Spain, 1994.

Authors:  A Domingo-Salvany; K Pérez; M Torrens; M J Bravo; J M Antó; J Alonso
Journal:  Drug Alcohol Depend       Date:  1999-08-02       Impact factor: 4.492

9.  Problematic heroin use incidence trends in Spain.

Authors:  Albert Sánchez-Niubò; Josep Fortiana; Gregorio Barrio; Josep Maria Suelves; Juan Francisco Correa; Antònia Domingo-Salvany
Journal:  Addiction       Date:  2009-02       Impact factor: 6.526

10.  Lessons from the history of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among Spanish drug injectors.

Authors:  L De La Fuente; M J Bravo; G Barrio; F Parras; M Suárez; A Rodés; I Noguer
Journal:  Clin Infect Dis       Date:  2003-12-15       Impact factor: 9.079

  10 in total
  16 in total

1.  Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.

Authors:  Maxim Polonsky; Lyuba Azbel; Jeffrey A Wickersham; Faye S Taxman; Evgeny Grishaev; Sergey Dvoryak; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2014-12-22       Impact factor: 4.492

Review 2.  Pharmacogenetics of Methadone Response.

Authors:  Francina Fonseca; Marta Torrens
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

3.  Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators.

Authors:  Maxim Polonsky; Julia Rozanova; Lyuba Azbel; Chethan Bachireddy; Jacob Izenberg; Tetiana Kiriazova; Sergii Dvoryak; Frederick L Altice
Journal:  AIDS Behav       Date:  2016-12

4.  A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013.

Authors:  Phillip L Marotta; Charlotte A McCullagh
Journal:  Eur J Epidemiol       Date:  2017-12-12       Impact factor: 8.082

5.  Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs.

Authors:  Sasha Uhlmann; Michael John Milloy; Keith Ahamad; Paul Nguyen; Thomas Kerr; Evan Wood; Lindsey Richardson
Journal:  Am J Addict       Date:  2015-03-24

6.  Accessing methadone within Moldovan prisons: Prejudice and myths amplified by peers.

Authors:  Maxim Polonsky; Lyuba Azbel; Jeffrey A Wickersham; Ruthanne Marcus; Svetlana Doltu; Evgeny Grishaev; Sergey Dvoryak; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2015-12-23

7.  Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine.

Authors:  Iuliia Makarenko; Alyona Mazhnaya; Ruthanne Marcus; Iryna Pykalo; Lynn Madden; Sergii Filippovich; Sergii Dvoriak; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2018-01-11

8.  Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine.

Authors:  Alexei Zelenev; Portia Shea; Alyona Mazhnaya; Julia Rozanova; Lynn Madden; Ruthanne Marcus; Frederick L Altice
Journal:  Drug Alcohol Depend       Date:  2018-06-30       Impact factor: 4.492

9.  The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.

Authors:  Martha J Bojko; Alyona Mazhnaya; Ruthanne Marcus; Iuliia Makarenko; Zahedul Islam; Sergey Filippovych; Sergii Dvoriak; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2016-03-24

Review 10.  The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.

Authors:  Frederick L Altice; Lyuba Azbel; Jack Stone; Ellen Brooks-Pollock; Pavlo Smyrnov; Sergii Dvoriak; Faye S Taxman; Nabila El-Bassel; Natasha K Martin; Robert Booth; Heino Stöver; Kate Dolan; Peter Vickerman
Journal:  Lancet       Date:  2016-07-14       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.